HAEMATO AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.7 EUR | -1.18% |
|
-4.57% | 0.00% |
| 1 week | -4.57% | ||
| Current month | -1.76% |
| Sales 2023 * | 268M 289M 394M | Sales 2024 * | 281M 303M 414M | Capitalization | 89.91M 97.01M 132M |
|---|---|---|---|---|---|
| Net income 2023 * | 7M 7.55M 10.3M | Net income 2024 * | 10M 10.79M 14.71M | EV / Sales 2023 * | 0.26 x |
| Net cash position 2023 * | 21.2M 22.88M 31.19M | Net cash position 2024 * | 24.2M 26.11M 35.6M | EV / Sales 2024 * | 0.23 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 76 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.67% |
More Fundamentals
* Assessed data
| 1 day | -1.18% | ||
| 1 week | -4.57% | ||
| Current month | -1.76% | ||
| 1 month | -8.74% | ||
| 3 months | +3.41% |
1 week
16.70
17.30
1 month
16.5018.70
Current year
15.0020.80
1 year
15.0020.80
3 years
15.0020.80
5 years
15.0020.80
10 years
15.0020.80
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-03 | 17.2 | +2.99% | 757 |
| 24-07-02 | 16.7 | -1.18% | 775 |
| 24-07-01 | 16.9 | -0.59% | 1,754 |
| 24-06-28 | 17 | +0.29% | 571 |
| 24-06-27 | 16.95 | -1.74% | 138 |
End-of-day quote Hanseatische Wertpapierboerse Hamburg, July 01, 2024
More quotes
Haemato AG, previously Windsor AG, is a Germany-based pharmaceutical company. The Company trades and patent-free and patent-protected medicines and generic drugs with focus on oncology, human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), neurology, rheumatology, urology, cardiovascular diseases and other chronic diseases. The Company's main markets are Europe, North America and Japan. It also imports medicines from within the European Economic Area in form of parallel imports and re-imports. The Company's subsidiaries are Haemato Pharm GmbH, Heamato Med GmbH, Castell Pharma BV, Sanate GmbH and Heamato Asia Co Ltd. Customers can order medicine through phone, fax and e-mail, among others.
Sector
Pharmaceuticals
Calendar
2024-07-16
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 93.73M | |
| +4.96% | 70.02B | |
| +16.65% | 9.05B | |
| -22.81% | 4.43B | |
| +14.83% | 4.16B | |
| +19.21% | 3.83B | |
| -1.86% | 2.06B | |
| +8.78% | 2.02B | |
| -36.94% | 1.9B | |
| -45.25% | 1.71B |
- Stock Market
- Equities
- HAEK Stock
